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Abstract
Epidemiological data on tuberculosis in Central Africa are limited.
We performed a retrospective observational study on clinical
characteristics of 719 hospitalized tuberculosis patients in Lam-
barene, Gabon. Human immunodeﬁciency virus (HIV) co-infection
rate was high (34%) and in-hospital mortality was signiﬁcantly
higher in HIV-positive patients (10% versus 2%). Long-term
information on patient outcome was limited; however, from
2008 to 2011, loss to follow up was noted in 28% of cases. Our
data illustrate the high burden of TB in Gabon, where loss to
follow up and emerging drug resistance are important problems
for which comprehensive data are still lacking.
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Introduction
One-third of the world population is estimated to be infected
with Mycobacterium tuberculosis [1]. Africa carries the highest
burden of the tuberculosis (TB) epidemic [1], but the success
of TB programmes in Africa is limited by poverty, high human
immunodeﬁciency virus (HIV) prevalence [2], logistic problems
and the emergence of drug-resistant M. tuberculosis strains [3].
Information on the state of the TB epidemic in Gabon, as for
most of Central Africa, is scarce [4].
The Albert Schweitzer Hospital (HAS) in Lambarene Gabon
is a 150-bed referral hospital in the Moyen Ogooue Province
and its patients originate from throughout central Gabon.
With this study we aim to describe the clinical characteristics
of TB patients in this rural to semi-rural setting.
Methods
We performed a retrospective observational study using the
patient register of the HAS Internal Medicine ward combined
with a separate TB case register. We included all patients
admitted to the internal medicine ward with a diagnosis of TB
from January 2007 to December 2012. The diagnosis of TB
was based on either a positive Ziehl–Neelsen-stained sputum
smear or on clinical grounds. Information on CD4 counts was
recovered from the laboratory register, using patient ID
numbers. All information was entered into a database and SPSS
(IBM SPSS statistics, version 19; SPSS Inc., Chicago, IL, USA)
was used for statistical analyses. Means were compared using a
t-test, no equal variances were assumed. Categorical data were
analysed by calculating odds ratios.
The study protocol was reviewed by the institutional
Scientiﬁc Review Committee and consecutively received ethical
clearance from the local Ethics Committee in Lambarene.
Results
We identiﬁed 719 patients with TB admitted to the HAS. The
proportion of TB cases among inpatients at the HAS remained
stable around 7–8%. The majority of the patients presenting
with TB at the HAS were male (55%) and the most common
age group was between 24 and 35 years (Table 1).
Pulmonary TBwas found in 607 (84%) patients. SputumZiehl–
Neelsen staining results were available in 503 (83%) patients, and
441 (88%)wereclassiﬁedaspositive.The typeofextra-pulmonary
TB was reported for 106 of the 112 patients; 63 were cases of
pleural TB, 22 cases of lymph node TB, 12 cases of peritoneal TB,
three cases of pericardial TB, two cases of visceral TB, two cases
of abdominal TB and two cases of TB in more than one site (one
lymph node and visceral TB and one pleural and peritoneal TB).
Follow-up data for patients were limited to mortality and
duration of stay for the majority of the study period. Overall
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mortality among TB patients was 5% (36 cases) and mortality
rates were similar for extra-pulmonary TB and pulmonary TB.
Mean duration of stay in the hospital for TB patients was
12 days. For the years 2008–2011, 28% of all patients
hospitalized with TB were marked as lost to follow up.
HIV testing was carried out in 605 patients (96%), of whom
205(34%)patientswereHIV-positive(Table 2).Extra-pulmonary
TB was more frequent in HIV-positive patients, but the
difference was not statistically signiﬁcant (OR 1.40, 95% CI
0.90–2.18). HIV-positive patients with pulmonary TB were less
likely to present with a positive Ziehl–Neelsen staining of
sputum (OR 0.51, 95% CI 0.34–0.77). CD4 counts were
obtained for 126 (61%) patients. The mean CD4 count was
296 (95% CI 246–345); 27% had a CD4 count <50 cells/lL, 48%
<200 cells/lL and 77% <500 cells/lL. Mortality was higher
among HIV-positive patients, and HIV patients who died were in
an advanced stage of infection with average CD4 count of
68 cells/lL (range 21–198 cells/lL).
Discussion
We describe a cohort of 719 TB patients hospitalized in the
semi-rural setting of the HAS in Lambarene, Gabon, during a
6-year timeframe (2007–2012). Gabon has one of the highest
incidences of TB in the central African region [1] and struggles
with a dysfunctional national TB programme. Our data
illustrate that TB afﬂicts mainly young adults (age group 24–
35 years), who are hospitalized for on average 12 days, placing
great ﬁnancial strains on families.
The HIV co-infection rate of 34% is similar to the recent
study of Kombila et al. [5] in TB patients in Libreville, which
reported a 32% co-infection rate. Previously, a study among
TB patients in Libreville in 2005 reported an HIV co-infection
rate of 26% [6], so the burden of HIV co-infection seems to be
increasing.
Our loss to follow up rate of 28% for the years 2008–
2011 is in accordance, albeit on the lower end, with
others who found rates between 26 and 61% [5–7]. The
absence of systematic records on long-term outcome of
TB patients also indicates sub-optimal follow up. Hence,
our data illustrate the failure of the Daily Observed
Therapy-Short Course (DOTS) strategy in Gabon [8].
Development of multidrug-resistant strains has already
been shown in a case series in Libreville [9], and early
evidence is accumulating at our study site (unpublished
data), but more research is needed to gain insight into the
extent of the problem.
TABLE 1. Characteristics of tuberculosis (TB) patients hospitalized in the Albert Schweizer Hospital in Lambarene, Gabon.
Absolute numbers are given combined with the percentage or 95% conﬁdence interval
2007 2008 2009 2010 2011 2012 Total
Hospitalized cases 1310 1500 1747 1930 1692 1537 9716
Hospitalized TB casesa 100 (8) 111 (7) 139 (8) 134 (7) 116 (7) 119 (8) 719 (7)
Average age (years) 37 (34.2–39.9) 39 (36.0–42.5) 36 (33.4–37.9) 35 (32.6–37.8) 37 (34.0–39.2) 36 (33.1–39.1) 37 (35.4–37.7)
Malesb 49 (49) 60 (54) 82 (59) 74 (55) 62 (53) 67 (56) 394 (55)
Extrapulmonary TBb 14 (14) 20 (18) 19 (14) 26 (19) 14 (12) 19 (16) 112 (16)
Ziehl–Neelsen-positivec 61 (71) 63 (69) 99 (83) 85 (79) 63 (62) 70 (70) 441 (73)
Admission duration (days) 12 (10.9–12.8) 11 (10.2–12.0) 11 (10.7–12.2) 11 (10.5–12.1) 12 (11.1–13.4) 13 (11.8–14.4) 12 (11.4–12.2)
Mortalityb 2 (2) 9 (8) 10 (7) 6 (4) 6 (5) 3 (3) 36 (5)
HIV-positivec 31 (37) 23 (28) 45 (36) 28 (25) 42 (46) 36 (33) 205 (34)
CD4 count in cells/lLd 312 (145–478) 235 (87–383) 400 (291–508) 290 (122–458) 254 (162–347) 254 (129–379) 296 (246–345)
Abbreviation: HIV, human immunodeﬁciency virus.
aPercentage of hospitalized cases.
bPercentage of TB cases.
cPercentage of TB cases for which results (for Ziehl–Neelsen staining or HIV testing) were available in HIV-positive patients only.
dIn HIV positive patients only.
TABLE 2. Characteristics of tuberculosis (TB) patients hospitalized in the Albert Schweizer Hospital in Lambarene, Gabon,
stratiﬁed by human immunodeﬁciency virus (HIV) status. Absolute numbers are given combined with the percentage or 95%
conﬁdence interval
HIV+ HIV Odds-ratio HIV+/HIV (95% CI) p value
Average age (years) 39 (37.8–41.1) 35 (33.1–36.2) 5.42 9 106
Male (%) 91 (44) 114 (61) 0.52 (0.37–0.73)
Extra-pulmonary TB (%) 40 (20) 59 (15) 1.40 (0.90–2.18)
Ziehl–Neelsen-positivea 119 (69) 319 (81) 0.51 (0.34–0.77)
Admission duration (days) 12 (11.4–13.1) 12 (11.3–12.1) 0.23
Mortality 20 (10) 7 (2) 6.06 (2.52–14.71)
aPercentage of TB cases for which results (for Ziehl–Neelsen staining or HIV testing) were available.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 19, E499–E501
E500 Clinical Microbiology and Infection, Volume 19 Number 11, November 2013 CMI
There are some limitations of our study that need to be
addressed. Most importantly, as the study has a retrospective
design, we were unable to check the clinical grounds for
diagnosing TB in the absence of positive Ziehl–Neelsen
staining of sputum. In addition, we were unable to check the
quality of data entry into the different registers used for this
study.
Despite these limitations, to our knowledge, this is the only
study describing clinical characteristics of TB patients in Gabon
outside the capital Libreville. By combining data from two
registers we are able to give a realistic account of hospitalized
TB patients in the HAS. Our ﬁndings illustrate the high burden
of TB and HIV in the Gabonese population. Loss to follow up is
a great problem in Gabon, especially in light of the develop-
ment of multidrug-resistant TB in the region. Hence, the
systematic collection of epidemiological data, improvement of
the national TB programme and the implementation of DOTS
are of utmost importance.
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